Athrogenic indexes: Useful markers for predicting metabolic syndrome in axial spondyloarthritis

Kassi, 2011, Metabolic syndrome: definitions and controversies, BMC Med, 9, 48, 10.1186/1741-7015-9-48 Pedro-Botet, 2018, COSMIC project: consensus on the objectives of the metabolic syndrome in clinic, Diabetes Metab Syndr Obes, 11, 683, 10.2147/DMSO.S165740 Alberti, 2009, Circulation, 120, 1640, 10.1161/CIRCULATIONAHA.109.192644 Koca, 2019, The clinical importance of the plasma atherogenic index, other lipid indexes, and urinary sodium and potassium excretion in patients with stroke, Eurasian J Med, 51, 172, 10.5152/eurasianjmed.2019.18350 Khakurel, 2018, Atherogenic index of plasma in postmenopausal women, J Nepal Health Res Counc, 16, 175, 10.33314/jnhrc.v16i2.1570 Pereira, 2009, Metabolic syndrome in rheumatological diseases, Autoimmun Rev, 8, 415, 10.1016/j.autrev.2009.01.001 Mok, 2011, Prevalence of atherosclerotic risk factors and the metabolic syndrome in patients with chronic inflammatory arthritis, Arthritis Care Res, 63, 195, 10.1002/acr.20363 Tam, 2010, Pathogenesis of ankylosing spondylitis, Nat Rev Rheumatol, 6, 399, 10.1038/nrrheum.2010.79 Huang, 2013, Increased risk of ischemic heart disease in young patients with newly diagnosed ankylosing spondylitis – a population-based longitudinal follow-up study, PLoS ONE, 8, e64155, 10.1371/journal.pone.0064155 Mathieu, 2015, Cardiovascular events in ankylosing spondylitis: an updated meta-analysis, Semin Arthritis Rheum, 44, 551, 10.1016/j.semarthrit.2014.10.007 Agca, 2017, EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update, Ann Rheum Dis, 76, 17, 10.1136/annrheumdis-2016-209775 Papadakis, 2009, High prevalence of metabolic syndrome and cardiovascular risk factors in men with ankylosing spondylitis on anti-TNFalpha treatment: correlation with disease activity, Clin Exp Rheumatol, 27, 292 Rudwaleit, 2009, The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (Part II): Validation and final selection, Ann Rheum Dis, 68, 777, 10.1136/ard.2009.108233 Lazarte, 2020, Pediatric dyslipidemia-beyond familial hypercholesterolemia, Can J Cardiol, 36, 1362, 10.1016/j.cjca.2020.03.020 Stone, 1994, Secondary causes of hyperlipidemia, Med Clin North Am, 78, 117, 10.1016/S0025-7125(16)30179-1 Garrett, 1994, A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index, J Rheumatol, 21, 2286 Lukas, 2009, Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis, Ann Rheum Dis, 68, 18, 10.1136/ard.2008.094870 Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA. 2001;285:2486–97. da Silva, 2018, Rev Port Cardiol, 37, 279, 10.1016/j.repc.2017.07.013 Bouguerra, 2006, Prevalence of metabolic abnormalities in the Tunisian adults: a population based study, Diabetes Metab, 32, 215, 10.1016/S1262-3636(07)70271-9 Naidu, 2019, Prevalence of metabolic syndrome in rheumatoid arthritis patients: a case–control study from a tertiary care centre in North India, J Assoc Physicians India, 67, 22 Gomes, 2018, Prevalence of metabolic syndrome in rheumatoid arthritis patients from Northeastern Brazil: association with disease activity, Mod Rheumatol, 28, 258, 10.1080/14397595.2017.1316813 Hallajzadeh, 2018, Metabolic syndrome and its components among women with polycystic ovary syndrome: a systematic review and meta-analysis, J Cardiovasc Thorac Res, 10, 56, 10.15171/jcvtr.2018.10 Giraud, 2021, The relationship between weight status and metabolic syndrome in patients with rheumatoid arthritis and spondyloarthritis, Joint Bone Spine, 88, 105059, 10.1016/j.jbspin.2020.07.008 Hammam, 2018, Metabolic syndrome in systemic lupus erythematosus patients: relationship to disease activity and neuropsychiatric lupus, Z Rheumatol, 77, 938, 10.1007/s00393-018-0447-0 Mobini, 2018, Metabolic syndrome in patients with systemic lupus erythematosus: association with disease activity, disease damage and age, Int J Rheum Dis, 21, 1023, 10.1111/1756-185X.13276 Maia, 2017, Metabolic syndrome in patients with ankylosing spondylitis receiving anti-TNFα therapy: association with predictors of cardiovascular risk, Clin Rheumatol, 36, 2371, 10.1007/s10067-017-3623-8 Pehlevan, 2014, Increased prevalence of metabolic syndrome in patients with psoriatic arthritis, Metab Syndr Relat Disord, 12, 43, 10.1089/met.2013.0039 Feld, 2018, Increased prevalence of metabolic syndrome and adipocytokine levels in a psoriatic arthritis cohort, J Clin Rheumatol Pract Rep Rheum Musculoskelet Dis, 24, 302 Raychaudhuri, 2012, Comorbidities of psoriatic arthritis – metabolic syndrome and prevention: a report from the GRAPPA 2010 annual meeting, J Rheumatol, 39, 437, 10.3899/jrheum.111244 Petcharat, 2021, Association between syndesmophyte and metabolic syndrome in patients with psoriatic arthritis or ankylosing spondylitis: a cross-sectional study, BMC Musculoskelet Disord, 22, 367, 10.1186/s12891-021-04222-8 Chen, 2009, TNF-alpha, a potent lipid metabolism regulator, Cell Biochem Funct, 27, 407, 10.1002/cbf.1596 Pishgahi, 2020, Immunological and oxidative stress biomarkers in Ankylosing Spondylitis patients with or without metabolic syndrome, Cytokine, 128, 155002, 10.1016/j.cyto.2020.155002 Costa, 2014, Impact of 24-month treatment with etanercept, adalimumab, or methotrexate on metabolic syndrome components in a cohort of 210 psoriatic arthritis patients, Clin Rheumatol, 33, 833, 10.1007/s10067-013-2369-1 Czókolyová, 2021, Changes of metabolic biomarker levels upon one-year anti-TNF-α therapy in rheumatoid arthritis and ankylosing spondylitis: associations with vascular pathophysiology, Biomolecules, 11, 1535, 10.3390/biom11101535 Stober, 2018, Prevalence and predictors of tumour necrosis factor inhibitor persistence in psoriatic arthritis, Rheumatology (Oxford), 57, 158, 10.1093/rheumatology/kex387 Jeong, 2019, C reactive protein level as a marker for dyslipidaemia, diabetes and metabolic syndrome: results from the Korea National Health and Nutrition Examination Survey, BMJ Open, 9, e029861, 10.1136/bmjopen-2019-029861 Min, 2020, Impact of TNF-α inhibitor on lipid profile and atherogenic index of plasma in axial spondyloarthritis: 2-year follow-up data from the Catholic Axial Spondyloarthritis COhort (CASCO), Clin Rheumatol, 39, 471, 10.1007/s10067-019-04767-z Tournadre, 2017, Changes in body composition and metabolic profile during interleukin 6 inhibition in rheumatoid arthritis, J Cachexia Sarcopenia Muscle, 8, 639, 10.1002/jcsm.12189 Summers, 2008, Rheumatoid cachexia: a clinical perspective, Rheumatol Oxf Engl, 47, 1124, 10.1093/rheumatology/ken146 Haroon, 2014, High prevalence of metabolic syndrome and of insulin resistance in psoriatic arthritis is associated with the severity of underlying disease, J Rheumatol, 41, 1357, 10.3899/jrheum.140021 Klingberg, 2019, Weight loss improves disease activity in patients with psoriatic arthritis and obesity: an interventional study, Arthritis Res Ther, 21, 17, 10.1186/s13075-019-1810-5 Romero-Talamás, 2014, Psoriasis improvement after bariatric surgery, Surg Obes Relat Dis Off J Am Soc Bariatr Surg, 10, 1155, 10.1016/j.soard.2014.03.025 Fernández-Macías, 2019, Atherogenic index of plasma: novel predictive biomarker for cardiovascular illnesses, Arch Med Res, 50, 285, 10.1016/j.arcmed.2019.08.009 Dobiásová, 2006, AIP-atherogenic index of plasma as a significant predictor of cardiovascular risk: from research to practice, Vnitr Lek, 52, 64 Onat, 2010, “Atherogenic index of plasma” (log10 triglyceride/high-density lipoprotein-cholesterol) predicts high blood pressure, diabetes, and vascular events, J Clin Lipidol, 4, 89, 10.1016/j.jacl.2010.02.005 Zhang, 2019, Association of metabolic syndrome with atherogenic index of plasma in an urban Chinese population: a 15-year prospective study, Nutr Metab Cardiovasc Dis, 29, 1214, 10.1016/j.numecd.2019.07.006